SYNCRIP and hepatocellular carcinoma: Notably, SYNCRIP was found to be involved in the acquisition of the migratory ability of HCC cells, as demonstrated by scratch assays of BW1J cells in which SYNCRIP knockdown significantly reduced cell motility (Figure 2G).